QUIDELORTHO CORP (QDEL) Stock Overview
USA - NASDAQ:QDEL - US2197981051 - Common Stock
QDEL Key Statistics, Chart & Performance
The current stock price of QDEL is 27.625 USD. In the past month the price decreased by -2.99%. In the past year, price decreased by -32.51%.
QDEL Latest News, Press Relases and Analysis
QDEL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.12 | 231.31B | ||
| ISRG | INTUITIVE SURGICAL INC | 55.34 | 159.70B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.08 | 142.90B | ||
| SYK | STRYKER CORP | 28.98 | 142.37B | ||
| MDT | MEDTRONIC PLC | 17.62 | 124.99B | ||
| BDX | BECTON DICKINSON AND CO | 13.49 | 55.17B | ||
| IDXX | IDEXX LABORATORIES INC | 52.64 | 50.58B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.33 | 44.26B | ||
| RMD | RESMED INC | 29.43 | 41.14B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.89 | 33.81B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.75 | 27.10B | ||
| DXCM | DEXCOM INC | 38.72 | 25.82B |
Related stock screener links
About QDEL
Company Profile
QuidelOrtho Corp. operates as a vitro diagnostics company. The company is headquartered in San Diego, California and currently employs 6,600 full-time employees. The firm specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. The company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
Company Info
QUIDELORTHO CORP
9975 Summers Ridge Road
San Diego CALIFORNIA 92121 US
CEO: Douglas C. Bryant
Employees: 6600
Phone: 18585521100
QUIDELORTHO CORP / QDEL FAQ
What is the stock price of QUIDELORTHO CORP today?
The current stock price of QDEL is 27.625 USD. The price decreased by -0.27% in the last trading session.
What is the ticker symbol for QUIDELORTHO CORP stock?
The exchange symbol of QUIDELORTHO CORP is QDEL and it is listed on the Nasdaq exchange.
On which exchange is QDEL stock listed?
QDEL stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for QUIDELORTHO CORP stock?
14 analysts have analysed QDEL and the average price target is 42.16 USD. This implies a price increase of 52.62% is expected in the next year compared to the current price of 27.625. Check the QUIDELORTHO CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is QUIDELORTHO CORP worth?
QUIDELORTHO CORP (QDEL) has a market capitalization of 1.88B USD. This makes QDEL a Small Cap stock.
How many employees does QUIDELORTHO CORP have?
QUIDELORTHO CORP (QDEL) currently has 6600 employees.
What are the support and resistance levels for QUIDELORTHO CORP (QDEL) stock?
QUIDELORTHO CORP (QDEL) has a support level at 27.7 and a resistance level at 29.98. Check the full technical report for a detailed analysis of QDEL support and resistance levels.
Is QUIDELORTHO CORP (QDEL) expected to grow?
The Revenue of QUIDELORTHO CORP (QDEL) is expected to decline by -2.47% in the next year. Check the estimates tab for more information on the QDEL EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy QUIDELORTHO CORP (QDEL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of QDEL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of QDEL, evaluating the profitability, health, valuation and growth aspects
- QUIDELORTHO CORP (QDEL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- QUIDELORTHO CORP (QDEL) Sales and EPS estimates to see what analysts future expectations are.
- QUIDELORTHO CORP (QDEL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- QUIDELORTHO CORP (QDEL) Insider and Institutional Ownership to learn about the owners and their transactions.
- QUIDELORTHO CORP (QDEL) Stock Chart to make your own analysis
- QUIDELORTHO CORP (QDEL) Latest news and press-releases to stay up to date.
Does QUIDELORTHO CORP (QDEL) stock pay dividends?
QDEL does not pay a dividend.
When does QUIDELORTHO CORP (QDEL) report earnings?
QUIDELORTHO CORP (QDEL) will report earnings on 2025-11-06, after the market close.
What is the Price/Earnings (PE) ratio of QUIDELORTHO CORP (QDEL)?
The PE ratio for QUIDELORTHO CORP (QDEL) is 11.81. This is based on the reported non-GAAP earnings per share of 2.34 and the current share price of 27.625 USD. Check the full fundamental report for a full analysis of the valuation metrics for QDEL.
What is the Short Interest ratio of QUIDELORTHO CORP (QDEL) stock?
The outstanding short interest for QUIDELORTHO CORP (QDEL) is 12.2% of its float. Check the ownership tab for more information on the QDEL short interest.
QDEL Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to QDEL. When comparing the yearly performance of all stocks, QDEL is a bad performer in the overall market: 88.75% of all stocks are doing better.
QDEL Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to QDEL. QDEL has a medium profitability rating, but doesn't score so well on its financial health evaluation.
QDEL Financial Highlights
Over the last trailing twelve months QDEL reported a non-GAAP Earnings per Share(EPS) of 2.34. The EPS decreased by -4.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -7.31% | ||
| ROE | -16.7% | ||
| Debt/Equity | 0.74 |
QDEL Forecast & Estimates
14 analysts have analysed QDEL and the average price target is 42.16 USD. This implies a price increase of 52.62% is expected in the next year compared to the current price of 27.625.
For the next year, analysts expect an EPS growth of 29.05% and a revenue growth -2.47% for QDEL